Connection
Hector Esquer to Enzyme Inhibitors
This is a "connection" page, showing publications Hector Esquer has written about Enzyme Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.140 |
|
|
|
-
Abbott JM, Zhou Q, Esquer H, Pike L, Broneske TP, Rinaldetti S, Abraham AD, Ramirez DA, Lunghofer PJ, Pitts TM, Regan DP, Tan AC, Gustafson DL, Messersmith WA, LaBarbera DV. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer. Mol Cancer Ther. 2020 08; 19(8):1598-1612.
Score: 0.140